Steve B. Park, M.D. is the founder of Cornerstone Eye Associates. After receiving a B.A. degree in chemistry from Northwestern University, he earned his M.D. degree from the University of Illinois at Chicago in 1986. He completed a medical internship at Beth Israel Hospital in New York City and then an ophthalmology residency at Case Western Reserve University Hospitals in Cleveland, Ohio. He came to Rochester to finish his sub specialty training in the Cornea and External Disease at the University of Rochester, NY.
Dr. Park's special interests are in cataract and corneal transplant surgeries, in addition to medical glaucoma. He has published over 25 articles and abstracts in peer reviewed medical journals. He is the first cataract surgeon in Rochester to have performed topical anesthesia cataract surgery and provides the most up to date technologies and techniques in the field. He is also the only corneal surgeon in Rochester to provide collagen cross linking for keratoconus and performs the latest corneal transplantation techniques such as endothelial transplantation.
Dr. Park is Board Certified by the American Board of Ophthalmology and is a Fellow of the American Academy of Ophthalmology. He is an active member of the American Society of Cataract and Refractive Surgery (ASCRS.) He currently is an assistant clinical professor in the Department of Ophthalmology at the University of Rochester School of Medicine.
Dr. Park's professional memberships include:
- American Academy of Ophthalmology (Fellow)
- American Society of Cataract and Refractive Surgery (ASCRS)
- Medical Society of the State of New York
- Monroe County Medical Society
- New York State Ophthalmological Society
After graduating with honors from the National University of Cordoba Medical School in his native Argentina, Dr. Hanuch completed a General Medical residency in Chicago's Hinsdale Hospital/Rush Medical School. He then completed a Post Doctoral Research Fellowship in Cornea and Refractive Surgery at the University of Rochester under the direction of Dr. James Aquavella, followed by a Surgical Ophthalmology Residency at the same institution.
His involvement in Refractive Surgery is reflected in important peer reviewed scientific publications in leading Ophthalmology journals. During this period, the National Eye Institute awarded him for his contributions to this field.
Dr. Hanuch is Board Certified in Ophthalmology and Family Medicine. He is a Fellow of the American Academy of Ophthalmology and The American College of Surgeons. He is a member of multiple professional associations including the International Society of Refractive Surgery as well as the American Society of Cataract and Refractive Surgery.
Dr. Hanuch is a Clinical Assistant Professor of Ophthalmology at the University of Rochester and has been actively involved in Refractive Surgery since its FDA approval in 1995. He brings his experience and the latest advancements to Cornerstone Eye Associates as they prove safe for his patients.
Furthermore, Dr. Hanuch is dedicated to providing compassionate care with state of the art technology in the diagnosis and treatment of patients with visual concerns. He welcomes any questions you might have about ways to improve your vision through refractive surgery.
Ying Qian, M.D., Ph.D. completed an ophthalmology residency at the University of Rochester Medical Center, and a Cornea and Refractive Surgery fellowship at the Massachusetts Eye and Ear Infirmary of Harvard Medical School. Dr. Qian is board certified by the American Academy of Ophthalmology.
Her clinical interests include cataract, advanced intraocular lens technology, corneal diseases & transplants, LASIK refractive surgery, and comprehensive eye care. She performs surgery at Westfall Surgery Center, Brighton Surgery Center, and Rochester General Hospital Surgery Center. She has medical staff privileges at the Strong Memorial Hospital and the Rochester Regional Health System, where she is also actively involved in resident teaching.
In addition to the clinical work, Dr. Qian conducted corneal transplantation research at the Schepens Eye Research Institute. She published her original work in peer reviewed medical journals such as Cornea, Archives of Ophthalmology, and Investigative Ophthalmology & Vision Science.
She is a member of American Academy of Ophthalmology, American Society of Cataract and Refractive Surgery, and International Society of Refractive Surgery.
David Allen Diloreto, Jr., M.D., Ph.D. is a retinal specialist. He was fellowship trained in medical and surgical retina at the Wilmer Ophthalmological Institute, Johns Hopkins University, in Baltimore, Maryland serving in both the Retinal Vasculature Center and the Vitreo-Retinal Services department.
In addition to his clinical work, Dr. Diloreto has a keen interest in clinical research providing patients with access to the latest therapies. He is currently an investigator in the AREDS2 trial to test if using supplements slows or prevents age related eye disease.
Dr. Diloreto earned his medical degree from the University of Rochester School of Medicine and Dentistry, as well as his doctorate degree in neurobiology and anatomy. He completed an internship at Highland Hospital and an Ophthalmology residency at the University of Southern California/Doheny Eye Institute.
He has received numerous awards, most recently the Knapp Fellowship from the Herman Knapp Testimonial Fund, the Ronald G. Michels Fellowship Foundation Award, and the Heed Fellowship from the Heed Ophthalmic Foundation.
Ajay Kuriyan, M.D., M.S., is an American Board of Ophthalmology Certified ophthalmologist retinal specialist. After graduating from the University of Rochester School of Medicine and Dentistry, he completed his ophthalmology residency and fellowship in vitreoretinal diseases at the Bascom Palmer Eye Institute, University of Miami.
Dr. Kuriyan's clinical interests encompass the medical and surgical treatment of retinal disease, including macular degeneration, diabetic eye disease, retinal vein occlusion, macular edema, retinal detachments, macular holes, epiretinal membranes, and hereditary retinal diseases.
Dr. Kuriyan is a member of the American Retina Society, the American Academy of Ophthalmology, the Association for Research in Vision and Ophthalmology, and the society of Heed Ophthalmic Fellows
Dr. Kuriyan has contributed to more than 50 peer reviewed articles, textbook chapters, presentations, and scientific posters. His specific research interests include developing novel compounds to inhibit proliferative vitreoretinopathy, the use and development of imaging technology to aid in earlier detection of retinal disease and provide prognostic information for visual outcomes, the management of endophthalmitis, and pediatric retinal disease.